CSE/GTII (CSE/GTII)

Canadian Securities Exchange: CSE/GTII · CAD

CA$9.00

+0.05 (+0.6%)· Recorded snapshot

Market cap	2B
Revenue (ttm)	1.7B
Net income (ttm)	180M
EPS (ttm)	CA$0.79
Shares out	218.6M
P/E (trailing)	11.4x
P/E (forward)	29.0x
Volume	13,633
Beta	0.95

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.7B
Net income (ttm): 180M
EPS (ttm): CA$0.79
P/E (trailing): 11.4x
P/E (forward): 29.0x
Market cap: 2B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E29

P25 n/aP50 n/aP75 n/a

Trailing P/E11.4

P25 n/aP50 n/aP75 n/a

ROE6.9

P25 n/aP50 n/aP75 n/a

ROIC2.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CSE/GTII indicators

Market & fundamental data

Available fields

235

Groups with data

Currency

USD

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-04
Employees	4,900
Employees change	-100
Employees growth	-2%
Enterprise value	CAD 2.4B
Exchange	Canadian Securities Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2014
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA39342L1085
Last earnings date	2026-08-04
Last refreshed	2026-10-29
Market cap	CAD 2B
Next earnings date	2026-11-04
Price	CAD 9.00
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-29
Symbol	cse/GTII
Website	https://www.gtigrows.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	31.18x
Average P/E ratio (3Y)	36.18x
Average P/E ratio (5Y)	48.13x
Earnings yield	8.74%
EV/Earnings	13.07x
EV/EBIT	14.45x
EV/EBITDA	5.17x
EV/FCF	8.38x
EV/Sales	1.37x
FCF / EV yield	11.94%
FCF yield	14.35%
Forward P/E	28.99x
Graham number	14.62205
Graham upside	63.37%
Industry forward P/E	34.4x
Lynch fair value	CAD 11.38
Lynch upside	27.12%
P/(FCF - SBC) ratio	8.95x
P/(OCF - SBC) ratio	6.12x
P/B ratio	0.74x
P/E ratio	11.44x
P/FCF ratio	6.97x
P/OCF ratio	5.12x
P/S ratio	1.14x
PEG ratio	144.93x
Price / tangible book value	1.68x
Price/EBITDA ratio	5.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	9.63%
EBITDA margin	22.2%
Effective tax rate	55.28%
FCF margin	16.6%
Gross margin	46.87%
Operating margin	9.63%
Pretax margin	23.19%
Profit margin	10.48%
Profit per employee	CAD 36,739
Profitable quarters	4
Profitable years	6
Revenue per employee	CAD 350,495
ROA	2.71%
ROA (5Y)	5.29%
ROCE	4.49%
ROE	6.85%
ROE (5Y)	3.98%
ROIC	2.45%
ROIC (5Y)	3.25%
SBC / revenue	3.62%
Tax / revenue	12.82%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	398.81%
EPS growth (QoQ)	-70.05%
EPS growth 5Y	13.32%
EPS growth quarters	4
EPS growth years	3
FCF growth	54.98%
FCF growth (Q)	-76.53%
FCF growth (QoQ)	-84.56%
FCF growth 5Y	69.72%
Gross profit growth	-4.76%
Gross profit growth (Q)	-5.73%
Gross profit growth 3Y	3.91%
Gross profit growth 5Y	6.12%
Net income growth	337.79%
Net income growth (QoQ)	-68.32%
Net income growth 5Y	14.46%
Net income growth quarters	4
Net income growth years	3
OCF growth	21.38%
OCF growth (Q)	-48.61%
OCF growth (QoQ)	-61.73%
OCF growth 3Y	8.33%
OCF growth 5Y	26.23%
Operating income growth	-36.03%
Operating income growth (Q)	-49.36%
Operating income growth 3Y	-13.41%
Operating income growth 5Y	-9.02%
Revenue growth	4.8%
Revenue growth (Q)	4.58%
Revenue growth (QoQ)	2.16%
Revenue growth 3Y	5.79%
Revenue growth 5Y	10.01%
Revenue growth quarters	12
Revenue growth years	9

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -101.3M
Depreciation and amortization	CAD 212.5M
EBIT	CAD 165.4M
EBITDA	CAD 381.2M
EPS	CAD 0.79
FCF per share	CAD 1.28
Financing cash flow	CAD -107.5M
Free cash flow	CAD 280.8M
Free cash flow minus SBC	CAD 218.7M
Gross profit	CAD 805M
Income taxes	CAD 220.1M
Investing cash flow	CAD -123.1M
Net borrowing	CAD 45.1M
Net cash flow	CAD 151.5M
Net income	CAD 180M
Operating cash flow minus SBC	CAD 319.9M
Operating income	CAD 165.4M
Revenue	CAD 1.7B
Stock-based compensation	CAD 62.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.88
Book value per share	CAD 12.08
Debt / EBITDA	1.74
Debt / equity	0.3
Debt / FCF	2.83
Goodwill	CAD 841.3M
Interest coverage	5.45
Long-term assets	CAD 3.1B
Long-term liabilities	CAD 1B
Net cash (debt)	CAD -392.8M
Net cash / market cap	-20.08%
Net debt / EBITDA	1.03
Net debt / equity	0.15
Net debt / FCF	1.4
Piotroski F-Score	5
Property, plant and equipment	CAD 1.3B
Shareholders' equity	CAD 2.6B
Tangible book value	CAD 1.2B
Tangible book value per share	CAD 5.34
Total assets	CAD 4B
Total cash	CAD 402.7M
Total debt	CAD 795.5M
Total liabilities	CAD 1.4B
WACC	7.24%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.45
Current assets	CAD 873.2M
Current liabilities	CAD 306M
Current ratio	2.85
Inventory turnover	3.86
Net working capital	CAD 237.8M
Quick ratio	1.54
Working capital	CAD 575.9M
Working capital turnover	5.44

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	3.68%
Shareholder yield	3.68%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 10.14
1D price change	0.56%
1M price change	-18.63%
1M total return	-18.63%
1W price change	-2.7%
1W total return	-2.7%
1Y price change	-9.37%
1Y return CAGR	-9.37%
1Y total return	-9.37%
20-day SMA	CAD 9.14
200-day SMA	CAD 9.96
3M price change	-6.64%
3M total return	-6.64%
3Y price change	-18.33%
3Y return CAGR	-6.53%
3Y total return	-18.33%
50-day SMA	CAD 9.96
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 14.39
52-week high date	2025-12-17
52-week low	CAD 7.40
52-week low date	2025-11-20
5Y price change	-63.71%
5Y return CAGR	-18.35%
5Y total return	-63.71%
6M price change	-17.13%
6M total return	-17.13%
All-time high	CAD 49.66
All-time high date	2021-02-10
All-time low	CAD 5.05
All-time low date	2020-03-16
Average true range (ATR)	CAD 0.36
Average volume	156.4K
Beta (1Y)	1
Beta (2Y)	1.13
Beta (5Y)	0.95
Change from 52-week high	-37.46%
Change from 52-week low	21.62%
Change from all-time high	-81.88%
Change from all-time low	78.22%
Change from open	-0.44%
Day's gap	1.01%
Dollar volume	CAD 122,697
High price	CAD 9.14
Low price	CAD 9.00
Monthly RSI	44.1
Open price	CAD 9.04
Position in 52-week range	0%
Previous close	CAD 8.95
Price vs 150-day SMA	-11.25%
Price vs 20-day SMA	-1.48%
Price vs 200-day SMA	-9.67%
Price vs 50-day SMA	-9.61%
Relative volume	0.09
RSI	42.78
Sharpe ratio	0.22
Sharpe ratio (3Y)	0.16
Sharpe ratio (5Y)	-0.04
Sortino ratio	0.48
Sortino ratio (3Y)	0.36
Sortino ratio (5Y)	0.02
Volume	13.6K
Weekly RSI	43.14
YTD price change	-18.33%
YTD total return	-18.33%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	191M
Shares change (QoQ)	-3.9%
Shares change (YoY)	-3.68%
Shares held by insiders	10.85%
Shares held by institutions	7.15%
Shares outstanding	218.6M

Deeper analysis on CSE/GTII

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/GTII report

Is a complete CSE/GTII research report available?

No complete published report is available for cse/GTII (CSE/GTII) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/GTII (CSE/GTII)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/GTII

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/GTII indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/GTII

Frequently asked questions